These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome. Hu P; Lu L; Hu B; Du PF Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931 [TBL] [Abstract][Full Text] [Related]
3. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome. Michaeli J; Bar-On H; Shafrir E Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786 [TBL] [Abstract][Full Text] [Related]
4. Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients. Wanner C; Krämer-Guth A; Nauck M; Quaschning T; Pavenstädt H; Schollmeyer P Miner Electrolyte Metab; 1996; 22(1-3):39-46. PubMed ID: 8676822 [TBL] [Abstract][Full Text] [Related]
5. Dietary cholesterol induced changes in lipid profile in patients with nephrotic syndrome and chronic renal failure. Jain PK; Arora RC; Agarwal N; Garg RK; Arora S; Gurbaxani RK; Sharma D J Assoc Physicians India; 1991 Oct; 39(10):751-3. PubMed ID: 1816199 [TBL] [Abstract][Full Text] [Related]
6. Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major. Al-Quobaili FA; Abou Asali IE Saudi Med J; 2004 Jul; 25(7):871-5. PubMed ID: 15235691 [TBL] [Abstract][Full Text] [Related]
7. Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles. Yoo WH J Rheumatol; 2004 Sep; 31(9):1746-53. PubMed ID: 15338494 [TBL] [Abstract][Full Text] [Related]
8. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins. Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239 [TBL] [Abstract][Full Text] [Related]
9. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults. Weltman A; Despres JP; Clasey JL; Weltman JY; Wideman L; Kanaley J; Patrie J; Bergeron J; Thorner MO; Bouchard C; Hartman ML Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility of non-HDL fraction to oxidation in experimental nephrotic syndrome. Dirican M; Taş S; Sarandöl E; Tokullugil HA Kobe J Med Sci; 1998 Dec; 44(5-6):235-45. PubMed ID: 10401226 [TBL] [Abstract][Full Text] [Related]
11. [Lipid metabolism in the nephrotic syndrome]. Tesar V; Merta M; Poledne R; Tĕmínová J; Zima T; Rychlík I; Zabka J; Stejskalová A Sb Lek; 1996; 97(1):143-50. PubMed ID: 8711410 [TBL] [Abstract][Full Text] [Related]
12. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Langsted A; Freiberg JJ; Nordestgaard BG Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664 [TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria. Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820 [TBL] [Abstract][Full Text] [Related]
14. Lipoproteins and lipid peroxidation abnormalities in patients with chronic renal disease. Ong-Ajyooth L; Ong-Ajyooth S; Sirisalee K; Nilwarangkur S J Med Assoc Thai; 1996 Aug; 79(8):505-12. PubMed ID: 8855633 [TBL] [Abstract][Full Text] [Related]
15. Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis. Antikainen M; Holmberg C; Taskinen MR Clin Nephrol; 1994 May; 41(5):284-9. PubMed ID: 8050208 [TBL] [Abstract][Full Text] [Related]
16. [Lipids, lipoproteins and apolipoproteins in normal newborns]. Casanueva V; Cid X; Chiang MT; Molina M; Ferrada MC; Pérez R; Casanueva P Rev Med Chil; 1998 Sep; 126(9):1073-8. PubMed ID: 9922510 [TBL] [Abstract][Full Text] [Related]
17. Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome. Prata MM; Nogueira AC; Pinto JR; Correia AM; Vicente O; Rodrigues MC; Miguel MJ Clin Nephrol; 1994 May; 41(5):277-83. PubMed ID: 8050207 [TBL] [Abstract][Full Text] [Related]
18. Impaired plasma viscosity via increased cholesterol levels in peripheral occlusive arterial disease [correction of disase]. Ercan M; Koksal C; Konukoglu D; Bozkurt AK; Onen S Clin Hemorheol Microcirc; 2003; 29(1):3-9. PubMed ID: 14561898 [TBL] [Abstract][Full Text] [Related]
19. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients. González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671 [TBL] [Abstract][Full Text] [Related]
20. Serum lipid concentrations correlate with the progression of chronic renal failure. Yang WQ; Song NG; Ying SS; Liang HQ; Zhang YJ; Wei MJ; Wu KF Clin Lab Sci; 1999; 12(2):104-8. PubMed ID: 10387487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]